Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Revenue for Roche Holding AG

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

RO: Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the...

270.20 CHF
Price
– CHF
Fair Value
–
Upside
232.40 - 333.60
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Roche Holding AG's Revenue:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 202450 B60 B70 B
Performance Summary
  • Roche's latest twelve months revenue is 62.395 billion
  • Roche's revenue for fiscal years ending December 2020 to 2024 averaged 62.969 billion.
  • Roche's operated at median revenue of 62.395 billion from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Roche's revenue peaked in December 2021 at 65.85 billion.
  • Roche's revenue hit its 5-year low in December 2020 of 60.343 billion.
  • Roche's revenue decreased in 2020 (60.343 billion, -5.3%), 2022 (65.814 billion, -0.1%), and 2023 (60.441 billion, -8.2%) and increased in 2021 (65.85 billion, +9.1%) and 2024 (62.395 billion, +3.2%).

How does Roche Holding's Revenue benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Roche Holding AG because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Roche Holding Revenue Benchmarks
NameTickerRevenue
HealthcareSECTOR:HLTH.CH398.2 M
H. Lundbeck A/SDB:LDBB2.95 B
Lonza Group AGSWX:LONN6.574 B
Merck KGaABRSE:MER19.887 B
GSK plcDB:GS7137.919 B
Bayer AGSWX:BAYN43.81 B
Bristol-Myers Squibb CoBRSE:BMY43.827 B
Sanofi SAENXTPA:SAN44.286 B
Novartis AGSWX:NOVN46.932 B
AstraZeneca PLCBRSE:00098235249.065 B
Merck & Co., Inc.BRSE:01068305358.225 B
Roche Holding AGSWX:RO62.395 B

Metric Usage: Revenue

Hide this widget
total_rev
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Revenue in the financials category include:

  • Preferred Stock Redeemable - Mandatorily redeemable securities of subsidiary companies.
  • Current Income Taxes Payable - This item represents the accrued portion of Income taxes levied on the Corporate Income. If Income Taxes are combined with any other taxes or any other liabilities, where income taxes appear as first string and the company does not report the break up for the same, then the same will form part of this data item only.
  • Other Intangibles - This item represents the net values of those assets (i.e. gross intangibles less accumulated amortization), which provide future economic benefit to the enterprise but have no physical form. It also includes the combined net amount of "Goodwill and Intangibles" (i.e. gross goodwill and intangibles as reduced by the accumulated amortization), where it is not possible to separately identify net goodwill and net intangibles.
  • Goodwill & Intangibles - The sum of all intangible asset fields
View Full List

Search for metric or datapoint

Revenue

The revenue metric captures the total income generated by a company from its core operational activities

Definition of Revenue

Hide this widget

Roche reported revenue of 62.395 B for the latest twelve months ending December 31, 2024 on its income statement.

The tables below summarises Roche’s Revenue over the last five years:

Fiscal Year Revenue
2020-12-31 60.343 B
2021-12-31 65.85 B
2022-12-31 65.814 B
2023-12-31 60.441 B
2024-12-31 62.395 B

The tables below summarizes Roche’s Revenue over the last four quarters:

Quarter Ending Revenue
2024-03-31 15.378 B
2024-06-30 15.378 B
2024-09-30 15.819 B
2024-12-31 15.819 B
Click the link below to download a spreadsheet with an example Revenue calculation for Roche Holding AG below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0 K5 B10 B19.008 B05001,0001,500

The chart above depicts the distribution of revenue for companies operating in the Healthcare sector in the Developed economic region. Over 2,020 companies were considered in this analysis, and 1,962 had meaningful values. The average revenue of companies in the sector is 569 M with a standard deviation of 1.922 B.

Roche Holding AG's Revenue of 62.395 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

Revenue In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,025
Included Constituents1,962
Min0 K
Max18.595 B
Median21.863 M
Mean569 M
Standard Deviation1.922 B

You can find companies with similar revenue using this stock screener.

All rights reserved. Terms Of Use